Zobrazeno 1 - 10
of 998
pro vyhledávání: '"B Borchardt"'
Publikováno v:
The Monist, 1900 Oct 01. 11(1), 143-144.
Externí odkaz:
https://www.jstor.org/stable/27899202
Autor:
Asveld, P.R.J.
Publikováno v:
Mathematical reviews, MR2234561/, 4734-4734. American Mathematical Society
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::aaf35059c98195272e29a1bf92d6870f
https://research.utwente.nl/en/publications/review-of-b-borchardt-a-maletti-b-seselja-a-tepavcevic-h-vogler-cut-sets-as-recognizable-tree-languages-fuzzy-sets-and-systems-157-2006-no-11-15601571(106fed9b-c203-4caa-a1aa-7a1ba225b801).html
https://research.utwente.nl/en/publications/review-of-b-borchardt-a-maletti-b-seselja-a-tepavcevic-h-vogler-cut-sets-as-recognizable-tree-languages-fuzzy-sets-and-systems-157-2006-no-11-15601571(106fed9b-c203-4caa-a1aa-7a1ba225b801).html
Autor:
Chenyang Shi, Thomas B. Borchardt
Publikováno v:
ACS Omega, Vol 2, Iss 12, Pp 8682-8688 (2017)
Externí odkaz:
https://doaj.org/article/5523c960e9c94a7d98c03880ceb891c7
Autor:
Kimberly B. Fitzpatrick, Nina Overgaard Therkildsen, Benjamin Marcy‐Quay, Harmony B. Borchardt‐Wier, Suresh A. Sethi
Publikováno v:
Fisheries Management and Ecology.
Publikováno v:
Molecular Pharmaceutics. 16:4751-4754
Amorphous solid dispersions (ASDs) are new formulations currently being used in pharmaceutical industry. The ASDs, in which amorphous drug and polymeric excipients are intimately mixed at the molecular level, exhibit dramatically enhanced solubility
Autor:
Alessandra Mattei, Rajni Miglani Bhardwaj, Ahmad Y. Sheikh, Sayan Mondal, Jianguo Ji, Keith F. McDaniel, Sun Guangxu, Thomas B. Borchardt, Richard S. Hong, Sizhu Li, M. Olivia Pierce, Lingle Wang, Michael A. Bellucci
Publikováno v:
Journal of chemical information and modeling. 61(3)
Drug design with patient centricity for ease of administration and pill burden requires robust understanding of the impact of chemical modifications on relevant physicochemical properties early in lead optimization. To this end, we have developed a p
Autor:
Russell T. Slade, David Lindley, Marjoleen Nijsen, Robert A. Carr, Patricia Stuart, Thomas B. Borchardt, Arian Emami Riedmaier, Jeffrey A. Hall, Daniel A.J. Bow, Steven Castleberry
Publikováno v:
Journal of Pharmaceutical Sciences. 107:495-502
Venetoclax, a selective B-cell lymphoma-2 inhibitor, is a biopharmaceutics classification system class IV compound. The aim of this study was to develop a physiologically based pharmacokinetic (PBPK) model to mechanistically describe absorption and d
Autor:
Xinmin (Sam) Xu, Gerald D. Danzer, Thomas B. Borchardt, Alessandra Mattei, Ahmad Y. Sheikh, Moiz Diwan, Raimundo Ho, Nadine Ding
Publikováno v:
Chemical Engineering in the Pharmaceutical Industry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69c48c7cb22cee4cdb06a126cae98e80
https://doi.org/10.1002/9781119600800.ch18
https://doi.org/10.1002/9781119600800.ch18
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.